Tokyo, March 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060887) titled 'A questionnaire survey on real-world treatment practices in patients receiving inhaled treprostinil therapy' on March 31.
Study Type:
Observational
Primary Sponsor:
Institute - Mochida Pharmaceutical Co., Ltd.
Condition:
Condition - Pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease (PH-ILD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to clarify real-world treatment practices in patients with PAH or PH-ILD receiving inhaled treprostinil therapy, with a particular focus on treatment satisfact...